The in vivo dose-response relationship between toluene and reactive oxygen species (ROS) formation in rat brain, liver, kidney, and lung, and the time-course of these effects has been characterized. The rate of oxygen radical formation was measured using the probe 2',7'-dichlorofluorescin diacetate. In vivo exposure to various doses of toluene (0.5, 1.0, and 1.5 g/kg ip) elicited a dose-dependent elevation of ROS generation within crude mitochondrial fractions obtained from rat lung and kidney, and within crude synaptosomal fractions from cerebellum. ROS formation in crude mitochondrial fractions from liver, and crude synaptosomal fractions from striatum and hippocampus, reached a maximum value at relatively low doses of toluene. Of the brain regions, the hippocampus had the highest induced levels of ROS. In vivo exposure to a single dose of toluene (1.5 g/kg ip), revealed that toluene-induced ROS reached a peak within 2 h, which correlated directly with measured toluene blood levels. This elevated oxidative activity was maintained throughout the next 24 h, even though blood values of toluene decreased to negligible amounts. These results demonstrate that exposure to toluene results in broad systemic elevation in the normal rate of oxygen radical generation, with such effects persisting in the tissues despite a rapid decline in
INTRODUCTION
Toluene is a widely used organic solvent. Human exposure to this agent may occur when toluene is in its pure form or when it is present as a component of paints, thinners, lacquers, and adhesives. In addition to the widespread industrial uses and potential for occupational exposures to toluene, this substance is a commonly abused solvent (Press and Done, 1967) . In this work environment, toluene comes into contact with the skin and the respiratory tract primarily in the form of vapors or liquid. On the average, 50% of inhaled toluene vapor is absorbed by the lung (Cohr and Stokholm, 1979) . Absorbed toluene is rapidly distributed through the blood to the tissues and organs.
A large number of epidemiological and experimental investigations of toluene have reported that exposure may produce signs and symptoms of nervous system dysfunction (Kelly, 1975; Boor and Hurtig, 1977; Maim and Lying, 1980; Fornazzari et al., 1983) . Several neurological deficits have been described in experimental animals following inhalation or intraperitoneal injection, including modified levels of enzymes (Korpela and Tahti, 1988), lipids (Kyrklund et al., 1987) , and specific neurotransmitter receptors (Yamawaki et al., 1982; Von Euler et al., 1988) . Behavioral and electroencephalic changes have also been reported (Naaslund, 1986; Rees et al., 1989) .
The mechanisms by which this organic solvent produces its effects are poorly understood. Recent studies have indicated that toluene neurotoxicity may be expressed through a membrane-associated event, such as, alteration of membrane fluidity and levels of intracellular Cat and Cat+regulated events (LeBel and Schatz, 1989, 1990; von Euler et al., 1990) . Toluene has been shown to induce morphological changes in astroglia and neurons in striatal primary cell cultures (Hansson et al., 1988) . In addition, altered receptor binding and increased levels of glutamine synthetase activity have been found in the cerebellum of toluene-exposed rats (Bjornaes and Naaslund, 1988) . Animal studies have suggested that extended toluene exposure may induce long-lasting morphological changes in the frontal cortex (Vasquez-Nin et al., 1980) and hippocampal and cerebellar regions (Ladefoged et al., 1991) .
There if some evidence that toluene exerts its toxicity by way of reactive oxygen species (ROS) formation. Exposure to toluene, both in vivo and in vitro, caused a significant elevation in ROS formation within
